Skip to content
Sleep Disorders

Zolpidem

Saiba mais sobre Zolpidem (Z-drug) for short-term insomnia. Dosagemm, efeitos secundários, and alternativas reviewed by EU-registered médicos via Prescrivia.

2026-04-12 Stilnoct

Preço mediante consulta

Inclui taxas de plataforma, revisão médica e cumprimento dependente da rota.

Dosagens e tipos

Este tratamento está visível apenas para fins informativos neste momento.

Nenhuma dosagem/tipo ativo está atualmente aberto para cumprimento por farmácia parceira através da plataforma.

O que é Zolpidem?

Zolpidem is a non-benzodiazepine hypnotic medicamento — commonly referred to as a Z-drug — utilizado para the short-term tratamento of insomnia, particularly where difficulty falling asleep is the primary complaint. It is available under several brand names across Europe, including Stilnoct and Sanval.

Zolpidem belongs to the imidazopyridine chemical class but shares a similar mechanism of action with benzodiazepines, acting on GABA-A receptors. However, its receptor subtype selectivity is considered to confer a somewhat different pharmacological profile, including comparatively less muscle relaxation and anxiolysis compared to classical benzodiazepines.

Como funciona Zolpidem work?

Zolpidem selectively enhances the activity of gamma-aminobutyric acid (GABA) at the GABA-A receptor complex by binding preferentially to the alpha-1 subunit. This receptor subtype is associated with sedation and hypnosis, which explains why zolpidem’s primary effects are sleep-promoting with relatively less muscle relaxation and anti-anxiety activity compared to classical benzodiazepines.

The result is:

  • Reduced sleep onset latency: Patients fall asleep faster
  • Increased total sleep time: Particularly in the earlier part of the night
  • Minimal disruption to sleep architecture: Zolpidem is considered to preserve normal sleep stages better than some longer-acting hypnotics

Zolpidem has a short half-life of approximately 2.4 hours (slightly longer in older adults and women), which is designed to allow sleep onset without excessive next-morning sedation.

Para quem é Zolpidem for?

Zolpidem is indicated for the short-term tratamento of insomnia in adults. It is particularly suited to sleep onset insomnia (difficulty falling asleep) rather than sleep maintenance insomnia (waking during the night), given its relatively short duration of action.

Clinical guidelines consistently recommend non-pharmacological interventions — in particular, Cognitive Behavioural Therapy for Insomnia (CBT-I) — as the primary tratamento for chronic insomnia. Zolpidem and other hypnotics are recommended only where:

  • CBT-I is unavailable or has been inadequate
  • The insomnia is acute and significantly impairing functioning
  • There is a clear short-term indication

Zolpidem is not appropriate for:

  • People with sleep apnoea syndrome
  • Those with myasthenia gravis or severe respiratory insufficiency
  • People with significant liver impairment
  • Those with a history of alcohol or substance dependence
  • Pregnant or breastfeeding women

Dosagem

Zolpidem is taken orally as a comprimido, immediately before going to bed. A full 7–8 hours of sleep should be available before any activities requiring alertness.

GroupRecommended DoseNotes
Adult women5 mg at bedtimeLower dose due to slower clearance
Adult men5–10 mg at bedtimeMay increase to 10 mg if 5 mg insufficient
Adults over 655 mg at bedtimeStart low; increased sensitivity
Maximum recommended duration2–4 weeksIncluding tapering period

The EMA updated its guidance on zolpidem dosing to recommend that women start at 5 mg due to evidence of higher morning blood concentrations and associated driving impairment risk.

Efeitos secundários

Efeitos secundários comuns (podem afetar mais de 1 em 10 pessoas)

  • Drowsiness or somnolence the following day
  • Headache
  • Dizziness
  • Nausea
  • Anterograde amnesia (difficulty forming new memories after taking the medicamento)

Serious risks

  • Complex sleep behaviours: Sleep-walking, sleep-driving, sleep-eating with no memory of events — risk is higher at doses above recommended levels and when combined with alcohol or CNS depressants
  • Next-morning impairment: Driving impairment may persist into the morning even after a full night’s sleep, particularly in women, older adults, or those taking higher doses
  • Dependence and withdrawal: Particularly with use beyond the recommended tratamento period
  • Rebound insomnia: Temporary worsening of sleep upon stopping tratamento
  • Hallucinations and psychiatric reactions: Including confusion, agitation, and hallucinations, particularly in older adults
  • Falls: Due to sedation and impaired coordination during the night

Zolpidem vs alternativas

MedicineClassPrimary IndicationHalf-LifeRx Required
ZolpidemZ-drugSleep onset insomnia~2–3 hoursYes
ZopicloneZ-drugSleep onset and maintenance~5–6 hoursYes
LormetazepamBenzodiazepineSevere insomnia~10–12 hoursYes
MelatoninHormoneCircadian disruption, jet lag~1–2 hoursLow dose: No
DiphenhydramineAntihistamineOccasional mild insomnia~9 hoursNo

Zopiclone may offer an advantage over zolpidem for pacientes with both sleep onset and sleep maintenance difficulties, given its longer half-life. A médico is best placed to determine which option is most clinically appropriate for individual pacientes.

Como aceder a sleep tratamento online na Europa

Zolpidem is a receita médica-only controlled medicamento across all estados-membros da UE. It cannot be legally dispensed without a valid receita médica from a licensed medical professional.

Prescrivia operates as a technology intermediary: our platform connects pacientes with independent EU-registered médicos who can conduct confidential online health assessments. We do not prescribe medicamentos, employ médicos, or dispense medicamentos directly.

The process is:

  1. Complete uma avaliação de saúde: Provide a structured health history, including details of your sleep difficulties, current medications, and relevant medical history.
  2. Avaliação médica: An independent EU-registered médico reviews your assessment. If a receita médica sleep medicamento is clinically appropriate, they may issue a receita médica.
  3. Receita e dispensa: If a receita médica is issued, it is forwarded to a licensed EU farmácia partner for dispensing and delivery.

Important: A Prescrivia não garante that a receita médica will be issued. All clinical decisions are made independently by qualified medical professionals.

Informação de segurança importante

Do not take Zolpidem if you have:

  • Sleep apnoea syndrome
  • Myasthenia gravis
  • Severe respiratory insufficiency or liver disease
  • A history of alcohol or drug dependence

Driving and machinery: Do not drive, cycle, or operate machinery after taking zolpidem. Morning impairment may persist into the following day, particularly in women and older adults. The EMA warns that zolpidem blood concentrations can remain above levels that impair driving ability for 7–8 hours after a 10 mg dose.

Alcohol: Never combine zolpidem with alcohol — the combination significantly enhances sedation and substantially increases the risk of complex sleep behaviours.

Fontes

Medical information on this page is based on the following sources:

  • Agência Europeia de Medicamentos (EMA). Questions and answers on zolpidem-containing medicamentos. EMA/CHMP/742257/2013.
  • Agência Europeia de Medicamentos (EMA). Assessment report on zolpidem. EMEA/H/A-31/1401.
  • Organização Mundial da Saúde (WHO). Management of sleep disorders — WHO guidelines. who.int

This content is reviewed periodically to reflect updated clinical guidance. It is provided for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for advice relevant to your individual health circumstances.

Frequently asked questions

O que é Zolpidem utilizado para?
Zolpidem is a sedative-hypnotic medicamento (Z-drug) prescribed for the short-term tratamento of insomnia characterised by difficulty falling asleep (sleep onset insomnia). It is a medicamento sujeito a receita médica across all estados-membros da UE and is intended for use over a maximum of 2–4 weeks.
Com que rapidez Zolpidem work?
Zolpidem is rapidly absorbed after oral administration, reaching peak plasma concentrations within approximately 30–120 minutes. Most pacientes experience sleep onset within 30 minutes of taking it. It should only be taken immediately before going to bed.
What are the risks of complex sleep behaviours with Zolpidem?
Zolpidem has been associated with sleep-related complex behaviours including sleep-walking, sleep-driving, sleep-eating, and making phone calls while asleep, with no memory of the events. These are more likely at higher doses or when zolpidem is combined with alcohol or other CNS depressants. Patients who experience any of these behaviours should stop zolpidem and contact their médico immediately.
Can Zolpidem cause dependence?
Yes. Like other hypnotic medicamentos, zolpidem carries a risk of tolerance and physical and psychological dependence, particularly with use beyond the recommended 2–4 week period. Rebound insomnia (worsening sleep after stopping) and withdrawal symptoms can occur on discontinuation. Dose tapering under medical guidance is recommended.
Is there a lower dose for women?
Yes. The EMA has recommended that women receive a lower starting dose of zolpidem (5 mg rather than 10 mg) because women clear the drug from their bodies more slowly than men, leading to higher blood concentrations in the morning and a greater risk of impaired driving. Your médico will determine the appropriate dose for you.

A Prescrivia é apenas uma plataforma intermediária. Não prestamos serviços médicos, não prescrevemos tratamentos nem dispensamos medicamentos. Todas as decisões médicas são tomadas por médicos independentes registados na UE. Todos os medicamentos são dispensados por farmácias licenciadas na UE. Esta plataforma facilita a ligação entre pacientes e prestadores de cuidados de saúde.

Written by Prescrivia Editorial. Medical information sourced from European Medicines Agency (EMA), World Health Organization (WHO), and published clinical data.

This content is informational only and does not constitute medical advice.

Last updated:

Pronto para começar?

Complete uma avaliação de saúde confidencial em cerca de 3 minutos.